1,483
Views
4
CrossRef citations to date
0
Altmetric
Editorial

In vivo veritas: Aspergillus fumigatus proliferation and pathogenesis – conditionally speaking

Pages 7-10 | Received 11 Dec 2015, Accepted 16 Dec 2015, Published online: 15 Jan 2016

References

  • Sasse A, Hamer SN, Amich J, Binder J, Krappmann S. Mutant characterisation and in vivo conditional repression identify aromatic amino acid biosynthesis to be essential for aspergillus fumigatus virulence. Virulence 2016:7(1):xxx-xxx.http://dx.doi.org/10.1080/21505594.2015.1109766
  • Latge JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999; 12:310-50; PMID:10194462
  • Tekaia F, Latge JP. Aspergillus fumigatus: saprophyte or pathogen? Curr Opin Microbiol 2005; 8:385-92; PMID:16019255; http://dx.doi.org/10.1016/j.mib.2005.06.017
  • Sugui JA, Kwon-Chung KJ, Juvvadi PR, Latge JP, Steinbach WJ. Aspergillus fumigatus and related species. Cold Spring Harbor Perspect Med 2015; 5:a019786; PMID:25377144; http://dx.doi.org/10.1101/cshperspect.a019786
  • Steinbach WJ. Are we there yet? Recent progress in the molecular diagnosis and novel antifungal targeting of Aspergillus fumigatus and invasive aspergillosis. PLoS Pathogens 2013; 9:e1003642; PMID:24204250; http://dx.doi.org/10.1371/journal.ppat.1003642
  • Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, White TC. Hidden killers: human fungal infections. Sci Transl Med 2012; 4:165rv13; PMID:23253612
  • Brown GD, Denning DW, Levitz SM. Tackling human fungal infections. Science 2012; 336:647; PMID:22582229; http://dx.doi.org/10.1126/science.1222236
  • Limper AH. The changing spectrum of fungal infections in pulmonary and critical care practice: clinical approach to diagnosis. Proc Am Thoracic Soc 2010; 7:163-8; PMID:20463243; http://dx.doi.org/10.1513/pats.200906-049AL
  • Kosmidis C, Denning DW. The clinical spectrum of pulmonary aspergillosis. Thorax 2015; 70:270-7; PMID:25354514; http://dx.doi.org/10.1136/thoraxjnl-2014-206291
  • Brock M. Fungal metabolism in host niches. Curr Opin Microbiol 2009; 12:371-6; PMID:19535285; http://dx.doi.org/10.1016/j.mib.2009.05.004
  • Fleck CB, Schobel F, Brock M. Nutrient acquisition by pathogenic fungi: nutrient availability, pathway regulation, and differences in substrate utilization. Int J Med Microbiol: IJMM 2011; 301:400-7; PMID:21550848; http://dx.doi.org/10.1016/j.ijmm.2011.04.007
  • Howard SJ, Webster I, Moore CB, Gardiner RE, Park S, Perlin DS, Denning DW. Multi-azole resistance in Aspergillus fumigatus. Int J Antimicrob Agents 2006; 28:450-3; PMID:17034993; http://dx.doi.org/10.1016/j.ijantimicag.2006.08.017
  • Snelders E, van der Lee HA, Kuijpers J, Rijs AJ, Varga J, Samson RA, Mellado E, Donders AR, Melchers WJ, Verweij PE. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med 2008; 5:e219; PMID:18998768; http://dx.doi.org/10.1371/journal.pmed.0050219
  • Moye-Rowley WS. Multiple mechanisms contribute to the development of clinically significant azole resistance in Aspergillus fumigatus. Front Microbiol 2015; 6:70; PMID:25713565; http://dx.doi.org/10.3389/fmicb.2015.00070
  • Verweij PE, Chowdhary A, Melchers WJ, Meis JF. Azole resistance in aspergillus fumigatus: can we retain the clinical use of mold-active antifungal azoles? Clin Infect Dis. 2015 Oct 20. pii: civ885; PMID:26486705
  • Wiederhold NP, Garcia Gil V, Gutierrez F, Lindner JR, Albataineh MT, McCarthy DI, Sanders C, Fan H, Fothergill AW, Sutton DA. First Detection of TR34/L98H and TR46/Y121F/T289A Cyp51 Mutations in Aspergillus fumigatus isolates in the United States. J Clin Microbiol 2016 Jan;54(1):168-71
  • Vogt K, Bhabhra R, Rhodes JC, Askew DS. Doxycycline-regulated gene expression in the opportunistic fungal pathogen Aspergillus fumigatus. BMC Microbiol 2005; 5:1; PMID:15649330; http://dx.doi.org/10.1186/1471-2180-5-1
  • Hu W, Sillaots S, Lemieux S, Davison J, Kauffman S, Breton A, Linteau A, Xin C, Bowman J, Becker J, et al. Essential gene identification and drug target prioritization in Aspergillus fumigatus. PLoS Pathogens 2007; 3:e24; PMID:17352532; http://dx.doi.org/10.1371/journal.ppat.0030024
  • Thykaer J, Andersen MR, Baker SE. Essential pathway identification: from in silico analysis to potential antifungal targets in Aspergillus fumigatus. Med Mycol 2009; 47 Suppl 1:S80-7; PMID:19253142; http://dx.doi.org/10.1080/13693780802455305
  • Carr PD, Tuckwell D, Hey PM, Simon L, d'Enfert C, Birch M, Oliver JD, Bromley MJ. The transposon impala is activated by low temperatures: use of a controlled transposition system to identify genes critical for viability of Aspergillus fumigatus. Eukaryotic Cell 2010; 9:438-48; PMID:20097738; http://dx.doi.org/10.1128/EC.00324-09
  • Lu Y, Deng J, Rhodes JC, Lu H, Lu LJ. Predicting essential genes for identifying potential drug targets in Aspergillus fumigatus. Comput Biol Chem 2014; 50:29-40; PMID:24569026; http://dx.doi.org/10.1016/j.compbiolchem.2014.01.011
  • Roemer T, Krysan DJ. Antifungal drug development: challenges, unmet clinical needs, and new approaches. Cold Spring Harbor Perspect Med 2014; 4; PMID:24789878
  • Lass-Florl C. Triazole antifungal agents in invasive fungal infections: a comparative review. Drugs 2011; 71:2405-19; PMID:22141384; http://dx.doi.org/10.2165/11596540-000000000-00000
  • Denning DW, Bromley MJ. Infectious disease. How to bolster the antifungal pipeline. Science 2015; 347:1414-6; PMID:25814567; http://dx.doi.org/10.1126/science.aaa6097
  • Casadevall A. Determinants of virulence in the pathogenic fungi. Fungal Biol Rev 2007; 21:130-2; PMID:19513186; http://dx.doi.org/10.1016/j.fbr.2007.02.007
  • Rhodes JC. Aspergillus fumigatus: growth and virulence. Med Mycol 2006; 44 Suppl 1:S77-81; PMID:17050423; http://dx.doi.org/10.1080/13693780600779419
  • Ben-Ami R, Lewis RE, Kontoyiannis DP. Enemy of the (immunosuppressed) state: an update on the pathogenesis of Aspergillus fumigatus infection. Br J Haematol 2010; 150:406-17; PMID:20618330
  • Dagenais TR, Keller NP. Pathogenesis of Aspergillus fumigatus in Invasive Aspergillosis. Clin Microbiol Rev 2009; 22:447-65; PMID:19597008; http://dx.doi.org/; http://dx.doi.org/10.1128/CMR.00055-08
  • Falkow S. Molecular Koch's postulates applied to microbial pathogenicity. Rev Infect Dis 1988; 10 Suppl 2:S274-6; PMID:3055197; http://dx.doi.org/10.1093/cid/10.Supplement_2.S274
  • Valiante V, Heinekamp T, Jain R, Hartl A, Brakhage AA. The mitogen-activated protein kinase MpkA of Aspergillus fumigatus regulates cell wall signaling and oxidative stress response. Fungal Genetics Biol: FG & B 2008; 45:618-27; PMID:17981060; http://dx.doi.org/10.1016/j.fgb.2007.09.006
  • Li H, Barker BM, Grahl N, Puttikamonkul S, Bell JD, Craven KD, Cramer RA Jr. The small GTPase RacA mediates intracellular reactive oxygen species production, polarized growth, and virulence in the human fungal pathogen Aspergillus fumigatus. Eukaryotic Cell 2011; 10:174-86; PMID:21183690; http://dx.doi.org/10.1128/EC.00288-10
  • Sasse C, Bignell EM, Hasenberg M, Haynes K, Gunzer M, Braus GH, Krappmann S. Basal expression of the Aspergillus fumigatus transcriptional activator CpcA is sufficient to support pulmonary aspergillosis. Fungal Genetics Biol: FG & B 2008; 45:693-704; PMID:18249572; http://dx.doi.org/10.1016/j.fgb.2007.12.008
  • Krappmann S, Bignell EM, Reichard U, Rogers T, Haynes K, Braus GH. The Aspergillus fumigatus transcriptional activator CpcA contributes significantly to the virulence of this fungal pathogen. Mol Microbiol 2004; 52:785-99; PMID:15101984; http://dx.doi.org/10.1111/j.1365-2958.2004.04015.x
  • Wanka F, Cairns T, Boecker S, Berens C, Happel A, Zheng X, Sun J, Krappmann S, Meyer V. Tet-on, or Tet-off, that is the question: Advanced conditional gene expression in Aspergillus. Fungal Genetics Biol. 2015 Nov 10. pii: S1087-1845(15)30044-X
  • Xu W, Solis NV, Ehrlich RL, Woolford CA, Filler SG, Mitchell AP. Activation and alliance of regulatory pathways in C. albicans during mammalian infection. PLoS Biol 2015; 13:e1002076; PMID:25693184; http://dx.doi.org/10.1371/journal.pbio.1002076
  • Pongpom M, Liu H, Xu W, Snarr BD, Sheppard DC, Mitchell AP, Filler SG. Divergent targets of Aspergillus fumigatus AcuK and AcuM transcription factors during growth in vitro versus invasive disease. Infect Immun 2015; 83:923-33; PMID:25534941; http://dx.doi.org/10.1128/IAI.02685-14

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.